u/mateusz_mensah

contraception interaction claims need citation

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

reship and retest is the honest way to handle a low result

This result fits the template perfectly. Logged.

Half-life is about 168 hours, so steady state lands around week 13–5. Practical consequence: what you feel in week 1 is not what that dose does.

integration decision on a shoulder changes your number by half a point on its own

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

Ran the same vial on two columns, different purity, both right, different separation. Method matters more than equipment.

small molecule purity is different testing than peptides

Did you actually measure heart rate or is that a feeling?

area% and mass% are not the same and this whole post conflates them

testing the vendor claim versus testing your actual vial are two different posts

This is an urgent-care question wearing a forum question's clothes.

Adding to this: below spec is doing more work than the comment implies.

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

Respectfully this is a sample of one presented as a finding.

Slight fix: the number was 97.6, not 97.4. Decimal point, but a fairly consequential one.

state the method: column, gradient, detection wavelength, injection volume

Yeah, the VendorInvestigate number matching the claim is the actual signal.

The PeptideMeter result being close to my own HPLC is the signal, not the absolute number. Both are right.